Serial Number 98731416
688

Registration Progress

Application Filed
Sep 3, 2024
Under Examination
Jun 24, 2025
Approved for Publication
Apr 29, 2025
Published for Opposition
Apr 29, 2025
Registered

Attorney Assistance

NOA E-Mailed - SOU Required
Due: Dec 24, 2025 48 days

Trademark Image

Basic Information

Serial Number
98731416
Filing Date
September 3, 2024
Published for Opposition
April 29, 2025
Drawing Code
2

Status Summary

Current Status
Active
Status Code
688
Status Date
Jun 24, 2025
Application
Pending
Classes
005

Rights Holder

Sonoma Biotherapeutics, Inc.

03
Address
201 Haskins Way
Suite 203
South San Francisco, CA 94080

Ownership History

Sonoma Biotherapeutics, Inc.

Original Applicant
03
South San Francisco, CA

Sonoma Biotherapeutics, Inc.

Owner at Publication
03
South San Francisco, CA

Legal Representation

Attorney
Thad Chaloemtiarana

USPTO Deadlines

Next Deadline
48 days remaining
NOA E-Mailed - SOU Required
Due Date
December 24, 2025
Extension Available
Until June 24, 2026

Application History

15 events
Date Code Type Description Documents
Jun 24, 2025 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Apr 29, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Apr 29, 2025 PUBO A PUBLISHED FOR OPPOSITION Loading...
Apr 23, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Apr 1, 2025 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Mar 27, 2025 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Mar 27, 2025 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Mar 27, 2025 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Mar 14, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
Mar 14, 2025 CNRT R NON-FINAL ACTION WRITTEN Loading...
Mar 14, 2025 GNRT F NON-FINAL ACTION E-MAILED Loading...
Mar 14, 2025 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Mar 13, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Mar 13, 2025 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Sep 4, 2024 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations, namely, cell therapy to treat diseases associated with inflammation such as autoimmune and neurodegenerative diseases, and biologic medications that reduce effector cells involved in diseases associated with inflammation such as autoimmune and neurodegenerative diseases

Additional Information

Design Mark
The mark consists of four large shaded ovals surrounded by four small shaded ovals.
Color Claim
Color is not claimed as a feature of the mark.

Classification

International Classes
005